US 11021424
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
granted A61KA61K31/355A61P
Quick answer
US patent 11021424 (Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers) held by PTC THERAPEUTICS, INC. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 85
- CPC classes
- A61K, A61K31/355, A61P, A61P13/02, A61P21/00